First-line Nab-paclitaxel Plus Cisplatin Plus Camrelizumab in mTNBC Patients
Clinical trial NCT04537286 · COMPLETED
Trial details
- NCT number
- NCT04537286
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2023-03-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.